Revenue
2010
2011
2012
Tanke Biosciences Corp (TNBI)
Price$0.018825Cached quote
Financial statements
| 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|
| Revenue | $28.6M | $23.8M | $20.1M | — |
| Gross profit | $9.9M | $8.8M | $7.4M | — |
| Gross margin | 34.82% | 36.80% | 36.82% | — |
| Research & development | $290,691 | $246,038 | — | — |
| Operating expenses | $5.4M | $7.0M | $3.0M | — |
| Operating income | $4.5M | $1.7M | $4.4M | — |
| Operating margin | 15.87% | 7.30% | 21.76% | — |
| EBITDA | $5.2M | $2.1M | $4.5M | — |
| EBITDA margin | 18.09% | 8.97% | 22.44% | — |
| Net income | −$210,247 | −$3.1M | $2.7M | $2.6M |
| Net profit margin | −0.74% | −13.16% | 13.62% | — |
| Basic EPSper basic share | -$0.02 | -$0.24 | $0.34 | — |
| Diluted EPSper diluted share | -$0.02 | -$0.24 | $0.34 | — |
Owners
Reported shareholders